These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 2046275
1. Hyperlipidemia of the nephrotic syndrome. Kaysen GA. Kidney Int Suppl; 1991 Apr; 31():S8-15. PubMed ID: 2046275 [No Abstract] [Full Text] [Related]
2. [Recent trends in the therapy of hyperlipidemia in nephrotic syndrome]. Campanacci L, Guarnieri GF, Faccini L, Bellini G, Gambari PF. G Clin Med; 1973 Oct; 54(10):714-33. PubMed ID: 4789301 [No Abstract] [Full Text] [Related]
3. [Mutual relation between hyperlipidemia and nephrotic syndrome]. Kraise Y, Averbuch M, Schwartz D, Kornovsky R, Levo Y. Harefuah; 1991 Dec 15; 121(12):521-4. PubMed ID: 1794760 [No Abstract] [Full Text] [Related]
4. [Nephrotic hyperlipidemia and its clinical significance]. Neverov NI, Srinivas KV. Ter Arkh; 1990 Dec 15; 62(6):150-3. PubMed ID: 2218917 [No Abstract] [Full Text] [Related]
5. [Hyperlipidemia in nephrotic syndrome]. Heaf JG. Ugeskr Laeger; 1991 Aug 26; 153(35):2414-6. PubMed ID: 1949240 [Abstract] [Full Text] [Related]
6. [Physiopathology of protein and lipid metabolism in the nephrotic syndrome. Recent experimental and clinical data]. Costică II, Dumitriu M. Fiziol Norm Patol; 1972 Aug 26; 18(2):145-54. PubMed ID: 5032189 [No Abstract] [Full Text] [Related]
8. [Abnormal lipid metabolism in nephrotic syndrome]. Mizobata R, Mune M. Nihon Rinsho; 2001 Mar 26; 59 Suppl 3():152-5. PubMed ID: 11347048 [No Abstract] [Full Text] [Related]
9. Treatment of hyperlipidemia in nephrotic syndrome: time for a change? Olbricht CJ, Koch KM. Nephron; 1992 Mar 26; 62(2):125-9. PubMed ID: 1436302 [No Abstract] [Full Text] [Related]
11. [Lipid metabolism disturbances in patients with nephrotic syndrome]. Zdrojewski Z. Pol Tyg Lek; 1992 Mar 26; 48(20-22):490-3. PubMed ID: 8170820 [No Abstract] [Full Text] [Related]
12. Rationale and management of hyperlipidemia of the nephrotic syndrome. Grundy SM, Vega GL. Am J Med; 1989 Nov 26; 87(5N):3N-11N. PubMed ID: 2486542 [Abstract] [Full Text] [Related]
13. [Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome]. Nikiforova NV. Biull Eksp Biol Med; 1966 Dec 26; 62(12):29-32. PubMed ID: 6005418 [No Abstract] [Full Text] [Related]